COVID-19

November 18, 2020November 16, 2020

A Fibromyalgia Thanksgiving

Columns, Tender Points - a Column by Christine Lynch

I’m not a holiday person. In truth, I never was. Sadly, depression rather than joy begins to set in for me just after Halloween and doesn’t let up until after ... Read more

September 29, 2020September 29, 2020

Aptinyx Reopens Enrollment in Phase 2 Study of NYX-2925 for Chronic Pain

News

Enrollment has resumed for Aptinyx‘s Phase 2 clinical trial of NYX-2925, an oral small molecule designed to treat chronic pain in adults with fibromyalgia, the company announced. The study (NCT04147858) is ... Read more

June 3, 2020June 1, 2020

Same Battle, New General: Restricted by Fibromyalgia and COVID-19

Columns, Tender Points - a Column by Christine Lynch

Fibromyalgia: Permission to stay at home, sir? COVID-19: Permission granted, soldier. Many consider COVID-19 to be the great disrupter. Those of us with fibromyalgia may see it differently. The only ... Read more

May 21, 2020May 22, 2020

UK Study to Look at COVID-19 Lockdown and Chronic Pain Patients

News

Versus Arthritis and the British Society for Rheumatology have awarded a £52,000 (about $63,600) grant to researchers at University of Aberdeen to study how the quarantine imposed by COVID-19 is ... Read more

April 30, 2020April 30, 2020

Phase 3 Trial of Bedtime Treatment, TNX-102 SL, Reaches Half Enrollment

News

The RELIEF Phase 3 trial assessing the safety and efficacy of TNX-102 SL (sublingual cyclobenzaprine) as a nighttime treatment of pain and disturbed sleep due to fibromyalgia has reached half of its ... Read more

April 27, 2020April 27, 2020

Surge in Telemedicine One ‘Good’ Outcome from COVID-19 Crisis, Doctors Say

News, syndicated

While there are few silver linings to the cloud created by COVID-19, the pandemic that has killed tens of thousands, hobbled economies worldwide and drove millions to quarantine in their ... Read more

April 2, 2020April 2, 2020

Pandemic Prompts Pause of Patient Enrollment in Fibromyalgia Trial of NYK-2925

News

In response to the COVID-19 pandemic, Aptinyx has temporarily suspended enrollment in its ongoing Phase 2b clinical trial investigating NYX-2925 in women with fibromyalgia. The company, however, has taken measures to make sure ... Read more